In addition, we noticed that immune pathways, such as TNFα-signaling through NF-kB, inflammatory response, IFN-α response, and IFN-γ response were significantly activated in GBM in the MMS22L low expression group. This evidence concerns the gene MMS22L and glioblastoma.